Citizens Financial Group Inc. RI Buys Shares of 478 Axon Enterprise, Inc. (NASDAQ:AXON)

Citizens Financial Group Inc. RI purchased a new stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 478 shares of the biotechnology company's stock, valued at approximately $284,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Asset Dedication LLC increased its position in shares of Axon Enterprise by 11.3% in the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company's stock valued at $106,000 after buying an additional 18 shares in the last quarter. Bleakley Financial Group LLC raised its position in shares of Axon Enterprise by 1.3% during the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company's stock worth $908,000 after purchasing an additional 20 shares during the period. Venturi Wealth Management LLC lifted its holdings in shares of Axon Enterprise by 2.7% during the 4th quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company's stock valued at $477,000 after purchasing an additional 21 shares in the last quarter. Insigneo Advisory Services LLC grew its position in shares of Axon Enterprise by 1.4% in the 3rd quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company's stock valued at $627,000 after purchasing an additional 22 shares during the period. Finally, Menard Financial Group LLC grew its position in shares of Axon Enterprise by 0.8% in the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company's stock valued at $1,204,000 after purchasing an additional 24 shares during the period. Institutional investors own 79.08% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on AXON shares. Robert W. Baird lifted their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an "outperform" rating in a research note on Friday, December 6th. The Goldman Sachs Group boosted their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a research report on Monday, January 27th. JMP Securities reiterated an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Craig Hallum lowered Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday. Finally, Needham & Company LLC reiterated a "buy" rating and set a $600.00 price objective on shares of Axon Enterprise in a report on Wednesday, February 26th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and eleven have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $604.67.

Remove Ads

Axon Enterprise Stock Down 4.2 %

AXON stock opened at $534.56 on Friday. The company has a market cap of $40.96 billion, a price-to-earnings ratio of 138.13, a P/E/G ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99. The business has a 50 day moving average price of $595.56 and a two-hundred day moving average price of $532.90. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Insider Activity

In other news, Director Michael Garnreiter sold 1,000 shares of the business's stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $639.69, for a total transaction of $639,690.00. Following the transaction, the director now directly owns 24,259 shares in the company, valued at $15,518,239.71. The trade was a 3.96 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Jeffrey C. Kunins sold 1,370 shares of the firm's stock in a transaction dated Tuesday, December 17th. The shares were sold at an average price of $639.14, for a total transaction of $875,621.80. Following the completion of the sale, the insider now owns 125,950 shares of the company's stock, valued at $80,499,683. This trade represents a 1.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 5,146 shares of company stock valued at $3,262,847. 6.10% of the stock is owned by insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.